Tekla World Healthcare Fund Current Valuation
| THW Fund | USD 11.82 0.13 1.09% |
Valuation analysis of Tekla World Healthcare helps investors to measure Tekla World's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Tekla World's price fluctuation is very steady at this time. At this time, the fund appears to be undervalued. Tekla World Healthcare has a current Real Value of $12.66 per share. The regular price of the fund is $11.82. We determine the value of Tekla World Healthcare from inspecting fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend buying undervalued funds and disposing overvalued funds since, at some point, fund prices and their ongoing real values will draw towards each other.
The fair value of the Tekla fund is determined by what a typical buyer is willing to pay for full or partial control of Tekla World Healthcare. Since Tekla World is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Fund. However, Tekla World's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.82 | Real 12.66 | Hype 11.95 | Naive 11.86 |
The intrinsic value of Tekla World's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tekla World's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tekla World Healthcare helps investors to forecast how Tekla fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla World more accurately as focusing exclusively on Tekla World's fundamentals will not take into account other important factors: Tekla World Healthcare Fund Current Valuation Analysis
Tekla World's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Tekla World Healthcare has a Current Valuation of 0.0. This indicator is about the same for the average (which is currently at 0.0) family and about the same as Current Valuation (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Tekla Fundamentals
| Shares Outstanding | 37.49 M | |||
| Shares Owned By Institutions | 11.77 % | |||
| Number Of Shares Shorted | 157.29 K | |||
| Price To Earning | 12.08 X | |||
| Short Ratio | 1.43 X | |||
| Earnings Per Share | 1.16 X | |||
| Beta | 1.03 | |||
| Market Capitalization | 600.4 M | |||
| Annual Yield | 0.01 % | |||
| Year To Date Return | 6.25 % | |||
| One Year Return | 14.09 % | |||
| Three Year Return | 1.24 % | |||
| Five Year Return | 6.22 % | |||
| Last Dividend Paid | 1.4 |
About Tekla World Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla World Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla World using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla World Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Tekla Fund
Tekla World financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla World security.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |